sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks 5-(3-PYRIDINYL)-1,3,4-OXADIAZOLE-2-THIOL

5-(3-PYRIDINYL)-1,3,4-OXADIAZOLE-2-THIOL

CAS No.:
3690-46-8
Catalog Number:
AG00BZ7B
Molecular Formula:
C7H5N3OS
Molecular Weight:
179.1991
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG00BZ7B
Chemical Name:
5-(3-PYRIDINYL)-1,3,4-OXADIAZOLE-2-THIOL
CAS Number:
3690-46-8
Molecular Formula:
C7H5N3OS
Molecular Weight:
179.1991
MDL Number:
MFCD00139080
IUPAC Name:
5-pyridin-3-yl-3H-1,3,4-oxadiazole-2-thione
InChI:
InChI=1S/C7H5N3OS/c12-7-10-9-6(11-7)5-2-1-3-8-4-5/h1-4H,(H,10,12)
InChI Key:
QBLWWQDTKCIRSW-UHFFFAOYSA-N
SMILES:
Sc1nnc(o1)c1cccnc1
Properties
Complexity:
229  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
179.015g/mol
Formal Charge:
0
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
179.197g/mol
Monoisotopic Mass:
179.015g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
78.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1  
Literature
Title Journal
Tetra-aqua-bis-(2-{[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]sulfan-yl}acetato)-cobalt(II) monohydrate. Acta crystallographica. Section E, Structure reports online 20111201
Tetra-aqua-bis-(2-{[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]sulfan-yl}acetato)-iron(II). Acta crystallographica. Section E, Structure reports online 20111001
Design, synthesis and biological evaluation of 1,3,4-oxadiazole derivatives. European journal of medicinal chemistry 20101101
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Studies on the synthesis and biological activity of 3-arylaminomethyl-5-(3-pyridyl)-1,3,4-oxadiazole-2-thione derivatives. Bollettino chimico farmaceutico 20010101
Properties